With a decade of product development funded by the NIH, we have been testing drug candidates with proven safety records to combat hearing disorders. Our lead product is undergoing a Phase II clinical trial as part of our exclusive contract from the U.S. Army. We have also initiated pre-clinical trials to test the efficacy of three drug candidates to treat tinnitus. Our innovative approach has earned us 7 SBIR/STTR grants, 2 patents, and 5 published papers.
